tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF

Newron Pharmaceuticals SpA (NWPHF) Revenue

Compare
9 Followers

Newron Pharmaceuticals SpA Revenue

Newron Pharmaceuticals SpA had a revenue of 47.98M in the quarter ending Dec 31, 2024, with 1308.37%. This bring the company's revenue in the last twelve months to 51.39M, Decreased 637.30%. In the fiscal year ending Dec 31, 2024, Newron Pharmaceuticals SpA had annual revenue of 51.39M with 467.41% growth.
Revenue (ttm)
51.39M
Revenue Growth
P/S Ratio
3.43
Revenue/Employee
$2,335,909
Employees
22
Market Cap
$176.52M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
51.39M42.33M+467.41%
Dec 31, 2023
9.06M2.96M+48.62%
Dec 31, 2022
6.09M332.00K+5.76%
Dec 31, 2021
5.76M504.00K+9.59%
Dec 31, 2020
5.26M-1.78M-25.29%
Dec 31, 2019
7.04M3.01M+74.86%
Dec 31, 2018
4.03M-9.40M-70.03%
Dec 31, 2017
13.43M6.70M+99.64%
Dec 31, 2016
6.73M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis